KSE - Delayed Quote KRW

Daewoong Co., Ltd. (003090.KS)

20,300.00
+50.00
+(0.25%)
At close: 3:30:30 PM GMT+9
Loading Chart for 003090.KS
  • Previous Close 20,250.00
  • Open 20,450.00
  • Bid 20,000.00 x --
  • Ask 20,050.00 x --
  • Day's Range 19,970.00 - 20,550.00
  • 52 Week Range 15,050.00 - 28,100.00
  • Volume 27,092
  • Avg. Volume 30,338
  • Market Cap (intraday) 830.081B
  • Beta (5Y Monthly) 1.26
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 12, 2025 - Aug 18, 2025
  • Forward Dividend & Yield 200.00 (0.99%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est 28,000.00

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South Korea.

www.daewoongholdings.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 003090.KS

View More

Performance Overview: 003090.KS

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

003090.KS
6.02%
KOSPI Composite Index (^KS11)
8.09%

1-Year Return

003090.KS
12.86%
KOSPI Composite Index (^KS11)
4.77%

3-Year Return

003090.KS
27.99%
KOSPI Composite Index (^KS11)
1.73%

5-Year Return

003090.KS
18.99%
KOSPI Composite Index (^KS11)
31.65%

Compare To: 003090.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 003090.KS

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    828.04B

  • Enterprise Value

    1.25T

  • Trailing P/E

    13.15

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    0.82

  • Enterprise Value/Revenue

    0.63

  • Enterprise Value/EBITDA

    2.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.99%

  • Return on Assets (ttm)

    6.87%

  • Return on Equity (ttm)

    4.69%

  • Revenue (ttm)

    1.94T

  • Net Income Avi to Common (ttm)

    57.89B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    264.14B

  • Total Debt/Equity (mrq)

    47.77%

  • Levered Free Cash Flow (ttm)

    -195.36B

Research Analysis: 003090.KS

View More

Company Insights: 003090.KS

Research Reports: 003090.KS

View More

People Also Watch